about
Using pharmacologic data to plan clinical treatments for patients with peritoneal surface malignancy.Hyperthermic intraperitoneal chemotherapy: Rationale and techniquePharmacokinetic and pharmacodynamic analysis of hyperthermic intraperitoneal oxaliplatin-induced neutropenia in subjects with peritoneal carcinomatosisComprehensive approach to advanced primary and recurrent ovarian cancer: a personal experience.Pharmacokinetics and tissue distribution of intraperitoneal 5-fluorouracil with a novel carrier solution in rats.Pharmacologic rationale for treatments of peritoneal surface malignancy from colorectal cancer.Rate and extent of oxaliplatin absorption after hyperthermic intraperitoneal administration in peritoneal carcinomatosis patients.Neutrophil dynamics in peritoneal carcinomatosis patients treated with cytoreductive surgery and hyperthermic intraperitoneal oxaliplatin.Implications of Hyperthermic Intraperitoneal Chemotherapy Perfusion-Related Hyperglycemia.Population pharmacokinetics of hyperthermic intraperitoneal oxaliplatin in patients with peritoneal carcinomatosis after cytoreductive surgery.Standard Clinical Protocol for Bidirectional Hyperthermic Intraperitoneal Chemotherapy (HIPEC): Systemic Leucovorin, 5-Fluorouracil, and Heated Intraperitoneal Oxaliplatin in a Chloride-Containing Carrier Solution.
P2860
Q33416610-D69375A0-7169-4CE4-9378-9193A9C629E9Q34391107-9E394C50-5E25-4FD2-AB10-4B67664A1FE1Q34544598-B5564526-51D2-4E8C-B709-EDEC3148D71BQ35782958-CF422DF0-7BB9-4927-8875-C8DFD0AB1F79Q37245482-806A2964-0A49-4AED-A679-16AB3C03DDB7Q41132998-7EC5815C-B6DF-48F6-97E7-BA160F790037Q42650614-338E90C7-A3BE-41D9-AB99-FBAE9E4D5B6DQ45243526-88C53E15-6CEE-48F8-B280-0AE153815D6EQ50076428-C9CA5984-1F21-415C-9A36-D11ECEB7D164Q50111382-4D132679-7E53-4DA3-BF5C-B3835423BF08Q52952846-2820EE41-ACB2-4503-A46E-85238DC4E0B9
P2860
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
2003年论文
@zh
2003年论文
@zh-cn
name
Carrier solutions for intraperitoneal chemotherapy.
@ast
Carrier solutions for intraperitoneal chemotherapy.
@en
type
label
Carrier solutions for intraperitoneal chemotherapy.
@ast
Carrier solutions for intraperitoneal chemotherapy.
@en
prefLabel
Carrier solutions for intraperitoneal chemotherapy.
@ast
Carrier solutions for intraperitoneal chemotherapy.
@en
P1476
Carrier solutions for intraperitoneal chemotherapy.
@en
P2093
Faheez Mohamed
Paul H Sugarbaker
P304
P356
10.1016/S1055-3207(03)00039-5
P577
2003-07-01T00:00:00Z